Taira Kiyota
Toronto, ON M5G0A3, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Structural Transformation of a BRAF Inhibitor into a Selective PKR Inhibitor.
Journal: Journal of medicinal chemistry
Published: June 22, 2026
Self-Dimerization Induced Proximity Targeting Chimeras (SDIPTAC) Lead to DCAF1 Loss of Function and Inhibition of HIV Replication.
Journal: Journal of medicinal chemistry
Published: May 18, 2026
Discovery and development of potent and selective dual NUAK/MARK inhibitors as Hippo pathway modulators for the treatment of cancer.
Journal: European journal of medicinal chemistry
Published: January 27, 2026
Discovery of pyrrolopyrimidinone inhibitors of the BCL6-SMRT corepressor interaction.
Journal: Bioorganic & medicinal chemistry
Published: December 16, 2025
Structure-based discovery of sulfamoyl-ethyl-4-oxo-3,4-dihydro-7H-pyrrolo[2,3-d]pyrimidine amides and sulfonamides as potent B-Cell Lymphoma 6 (BCL6)-BTB inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: October 27, 2025
OICR-41103 as a chemical probe for the DCAF1 WD40 domain.
Journal: Communications biology
Published: January 17, 2025
Discovery of Conformationally Constrained ALK2 Inhibitors.
Journal: Journal of medicinal chemistry
Published: March 18, 2024
A Workflow for Meaningful Interpretation of Classification Results from Handheld Ambient Mass Spectrometry Analysis Probes.
Journal: International journal of molecular sciences
Published: January 23, 2024
Discovery of OICR12694: A Novel, Potent, Selective, and Orally Bioavailable BCL6 BTB Inhibitor.
Journal: ACS medicinal chemistry letters
Published: November 30, 2022
Last Updated: 09/26/2026